ProCE Banner Activity


Optimizing the Management of EoE: Key Insights From the Allergist’s Perspective


Eosinophilic esophagitis remains underrecognized and undertreated, despite the availability of FDA-approved therapy. Watch this on-demand webcast to hear expert allergist insights on the latest clinical data on new and emerging therapies that target the underlying triggers of this disease.

Physicians: Maximum of 1.50 AMA PRA Category 1 Credits

Physician Assistants/Physician Associates: 1.50 AAPA Category 1 CME credits

Nurses: 1.50 Nursing contact hours

Released: March 21, 2023

Expiration: March 20, 2024

No longer available for credit.



Sameer Mathur

Sameer Mathur, MD, PhD

Associate Professor
Division of Allergy, Pulmonary and Critical Care
Department of Medicine
University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin

Seema Aceves

Seema Aceves, MD, PhD

Professor, Pediatrics and Medicine
Director, EGID Clinic Rady Childrens Hospital
Allergy, Immunology
University of California, San Diego
La Jolla, California

Melanie Ruffner

Melanie Ruffner, MD, PhD

Assistant Professor
University of Pennsylvania
Attending Physician
Center for Pediatric Eosinophilic Disorders and Divisions of Allergy and Immunology
Childrens Hospital of Philadelphia
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner


This educational activity is supported by an education grant from

Regeneron Pharmaceuticals, Inc


Target Audience

The proposed educational program is intended for US-based and OUS-based physicians, nurse practitioners, and physician associates/physician assistants in allergy/immunology settings caring for patients with EoE.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of allergy/immunology learners to optimize treatment for patients with EoE.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Differentiate EoE from other types of food allergy using evidence-based guidelines and diagnostic criteria

  • Analyze current and emerging treatments based on their impact on disease outcomes in patients with EoE

  • Employ strategies to effectively transition adolescent and young adult patients with EoE from pediatric to adult care


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Seema S. Aceves, MD, PhD: consultant/advisor/speaker: AstraZeneca, Regeneron/Sanofi; royalties or patent beneficiary: Takeda.

Sameer K. Mathur, MD, PHD: consultant/advisor/speaker: AstraZeneca, GlaxoSmithKline, Regeneron.

Melanie Ruffner, MD, PhD, has no relevant financial relationships to disclose.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.5 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from March 21, 2023, through March 20, 2024:

  1. Create an account or Login at
  2. Read the target audience, learning objectives, and faculty disclosures
  3. View and study the content in its entirety
  4. Submit answers to the post-test questions and evaluation questions online

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by clicking the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.


This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

Credit Designation
CCO designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.50 contact hours.

Physician Assistant/Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. Approval is valid until March 20, 2024. PAs should only claim credit commensurate with the extent of their participation.